SLV308 -: Antiparkinsonian -: Antidepressant -: Anxiolytic -: Dopamine D2 partial agonist -: 5-HT1A agonist

被引：9
|
作者：
Feenstra, R [1 ]
Ronken, E [1 ]
Koopman, T [1 ]
de Vries, M [1 ]
McCreary, A [1 ]
Stoker, M [1 ]
van Charldorp, K [1 ]
Long, S [1 ]
van Scharrenburg, G [1 ]
机构：
[1] Solvay Pharmaceut, NL-1380 DA Weesp, Netherlands
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 02期
关键词：
D O I：
10.1358/dof.2001.026.02.608830
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：128 / 132
页数：5
相关论文
共 50 条
  • [31] F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential
    Koek, W
    Patoiseau, JF
    Assie, MB
    Cosi, C
    Kleven, MS
    Dupont-Passelaigue, E
    Carilla-Durand, E
    Palmier, C
    Valentin, JP
    John, G
    Pauwels, PJ
    Tarayre, JP
    Colpaert, FC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (01) : 266 - 283
  • [32] On the elevated plus maze the anxiolytic like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635
    Collinson, N
    Dawson, GR
    PSYCHOPHARMACOLOGY, 1997, 132 (01) : 35 - 43
  • [33] The novel dopamine D2 receptor partial agonist, SLV-308, reverses motor disability in MPTP-lesioned common marmosets (Callithrix jacchus).
    Johnston, LC
    Smith, L
    Rose, S
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133
  • [34] Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
    Auclair, Agnes L.
    Galinier, Alexandra
    Besnard, Joel
    Newman-Tancredi, Adrian
    Depoortere, Ronan
    PSYCHOPHARMACOLOGY, 2007, 193 (01) : 45 - 54
  • [35] EFFECTS OF THE PUTATIVE 5-HT1A AGONIST ANXIOLYTIC, IPSAPIRONE, ON BENZODIAZEPINE WITHDRAWAL IN RATS
    GOUDIE, AJ
    LEATHLEY, MJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 : P558 - P558
  • [36] F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: Influence on neuronal firing and neurotransmitter release
    Assie, Marie-Bernadette
    Mnie-Filali, Ouissame
    Ravailhe, Veronique
    Benas, Christelle
    Marien, Marc
    Betry, Cecile
    Zimmer, Luc
    Haddjeri, Nasser
    Newman-Tancredi, Adrian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 607 (1-3) : 74 - 83
  • [37] Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic
    Keck, PE
    McElroy, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 655 - 662
  • [38] The Synthesis of a Dopamine D2 Partial Agonist for the Treatment of Schizophrenia
    Magano, Javier
    Acciacca, Alison
    Akin, Anne
    Collman, Benjamin M.
    Conway, Brian
    Waldo, Michael
    Chen, Michael H.
    Mennen, Kenneth E.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (03) : 555 - 566
  • [39] Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors?
    D. M. Jackson
    Hakån Wikström
    Y. Liao
    Psychopharmacology, 1998, 138 : 213 - 214
  • [40] Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
    Agnès L. Auclair
    Alexandra Galinier
    Joël Besnard
    Adrian Newman-Tancredi
    Ronan Depoortère
    Psychopharmacology, 2007, 193 : 45 - 54
12345